99 related articles for article (PubMed ID: 8341280)
1. Associated complement C3b. Towards an understanding of its intracellular modifications.
Rey-Millet CA; Chesne S; Colomb MG
Mol Immunol; 1993 Jul; 30(10):855-64. PubMed ID: 8341280
[TBL] [Abstract][Full Text] [Related]
2. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
4. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
Gadd KJ; Reid KB
Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin processing by thyroidal proteases. Major sites of cleavage by cathepsins B, D, and L.
Dunn AD; Crutchfield HE; Dunn JT
J Biol Chem; 1991 Oct; 266(30):20198-204. PubMed ID: 1939080
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of membrane bound C3bi, an intermediate of the third component of complement, to C3c and C3d-like fragments by crude leucocyte lysosomal lysates and purified leucocyte elastase.
Carlo JR; Spitznagel JK; Studer EJ; Conrad DH; Ruddy S
Immunology; 1981 Oct; 44(2):381-91. PubMed ID: 7028603
[TBL] [Abstract][Full Text] [Related]
7. C3b covalently associated to tetanus toxin modulates TT processing and presentation by U937 cells.
Rey-Millet CA; Villiers CL; Gabert FM; Chesne S; Colomb MG
Mol Immunol; 1994 Dec; 31(17):1321-7. PubMed ID: 7997244
[TBL] [Abstract][Full Text] [Related]
8. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
[TBL] [Abstract][Full Text] [Related]
9. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
Medof ME; Iida K; Mold C; Nussenzweig V
J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
[TBL] [Abstract][Full Text] [Related]
10. Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells.
Brix K; Lemansky P; Herzog V
Endocrinology; 1996 May; 137(5):1963-74. PubMed ID: 8612537
[TBL] [Abstract][Full Text] [Related]
11. Action of the C3b-inactivator on the cell-bound C3b.
Law SK; Fearon DT; Levine RP
J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
[TBL] [Abstract][Full Text] [Related]
12. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
Medicus RG; Melamed J; Arnaout MA
Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
[TBL] [Abstract][Full Text] [Related]
13. Limited proteolysis of complement protein C3b by regulatory enzyme C3b inactivator: isolation and characterization of a biologically active fragment, C3d,g.
Seya T; Nagasawa S
J Biochem; 1985 Jan; 97(1):373-82. PubMed ID: 3158646
[TBL] [Abstract][Full Text] [Related]
14. Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase.
Delaissé JM; Ledent P; Vaes G
Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):167-74. PubMed ID: 1930136
[TBL] [Abstract][Full Text] [Related]
15. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of complement activation by crystalline cholesterol.
Vogt W; von Zabern I; Damerau B; Hesse D; Lühmann B; Nolte R
Mol Immunol; 1985 Feb; 22(2):101-6. PubMed ID: 3156272
[TBL] [Abstract][Full Text] [Related]
17. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
Fries LF; Gaither TA; Hammer CH; Frank MM
J Exp Med; 1984 Dec; 160(6):1640-55. PubMed ID: 6239898
[TBL] [Abstract][Full Text] [Related]
18. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
[TBL] [Abstract][Full Text] [Related]
19. Natural release of covalently bound C3b from cell surfaces and the study of this phenomenon in the fluid-phase system.
Venkatesh YP; Minich TM; Law SK; Levine RP
J Immunol; 1984 Mar; 132(3):1435-9. PubMed ID: 6693771
[TBL] [Abstract][Full Text] [Related]
20. Proteolysis of C3 on U937 cell plasma membranes. Purification of cathepsin G.
Maison CM; Villiers CL; Colomb MG
J Immunol; 1991 Aug; 147(3):921-6. PubMed ID: 1861080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
